NICE Give Approval for Sankyo’s Blood Thinner Lixiana
The National Institute for Health and Care Excellence (NICE) has given final recommendation for Sankyo’s blood thinner Lixiana (edoxaban) to be used for the treatment and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults.